10 septiembre 2014
Imaging technologies are useful in evaluating response to cancer treatment, and this can be done quite effectively for most tumors using RECIST, Response Evaluation Criteria in Solid Tumors. RECIST works well for tumors located in soft tissue, but not cancers that spread to the bone. More effort, therefore, is needed to improve our understanding of how to monitor the response of bone metastases to treatment using MRI and PET imaging.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/GquLY1rqcFc/140910120422.htm
